UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 336

Sortiert nach

Missed therapeutic and prevention opportunities in women with BRCA‐mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature

CA: a cancer journal for clinicians, 2017-11, Vol.67 (6), p.493-506

2017

Volltextzugriff (PDF)

Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group

Journal of clinical oncology, 2011-08, Vol.29 (24), p.3278-3285

2011

Volltextzugriff (PDF)

Low-Stage Ovarian Clear Cell Carcinoma: Population-Based Outcomes in British Columbia, Canada, With Evidence for a Survival Benefit As a Result of Irradiation

Journal of clinical oncology, 2012-05, Vol.30 (14), p.1656-1662

2012

Volltextzugriff (PDF)

International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: Altered Utility in the Modern Era

Journal of clinical oncology, 2012-09, Vol.30 (27), p.3383-3388

2012

Volltextzugriff (PDF)

Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2008-11, Vol.26 (32), p.5165-5169

2008

Volltextzugriff (PDF)

Single or two drug combination therapy as initial treatment for low risk, gestational trophoblastic neoplasia. A Canadian analysis

Gynecologic oncology, 2020-05, Vol.157 (2), p.367-371

2020

Volltextzugriff (PDF)

Phase II Study of Erlotinib in Recurrent or Metastatic Endometrial Cancer: NCIC IND-148

Journal of clinical oncology, 2008-09, Vol.26 (26), p.4319-4325

2008

Volltextzugriff (PDF)

Time for a level playing field: inequalities in regulatory/approval processes—the example of bevacizumab in epithelial ovarian cancer

Journal of clinical oncology, 2015-05, Vol.33 (14), p.1539-1542

2015

Volltextzugriff (PDF)

Paclitaxel and Carboplatin, Alone or With Irradiation, in Advanced or Recurrent Endometrial Cancer: A Phase II Study

Journal of clinical oncology, 2001-10, Vol.19 (20), p.4048-4053

2001

Volltextzugriff (PDF)

Which is the better surgical strategy for newly diagnosed epithelial ovarian cancer: primary or interval debulking?

Current opinion in oncology, 2011-09, Vol.23 (5), p.501-506

Hoskins, Paul J

2011

Volltextzugriff (PDF)

Early-Stage Endometrioid Ovarian Carcinoma: Population-Based Outcomes in British Columbia

International journal of gynecological cancer, 2014-10, Vol.24 (8), p.1401-1405

2014

Volltextzugriff (PDF)

Triple cytotoxic therapy for advanced ovarian cancer: a failed application, not a failed strategy

Journal of clinical oncology, 2009-03, Vol.27 (9), p.1355-1358

Hoskins, Paul J

2009

Volltextzugriff (PDF)

Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines

Blood advances, 2021-03, Vol.5 (5), p.1483-1489

2021

Volltextzugriff (PDF)

Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma

Leukemia & lymphoma, 2017-02, Vol.58 (2), p.324-332

2017

Volltextzugriff (PDF)

Survival Benefit of Adjuvant Radiotherapy: An Analysis of Low-Stage Invasive Ovarian Mucinous Carcinomas

International journal of gynecological cancer, 2017-11, Vol.27 (9), p.1819-1825

2017

Volltextzugriff (PDF)

Reuse of carboplatin and paclitaxel in patients with relapsed endometrial cancer—the British Columbia Cancer Agency experience

Gynecologic oncology, 2008-12, Vol.111 (3), p.474-477

2008

Volltextzugriff (PDF)

Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: Potential implications for future prophylaxis recommendations

Leukemia & lymphoma, 2005-07, Vol.46 (7), p.1085-1089

2005

Volltextzugriff (PDF)

Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience

Gynecologic oncology, 2008-01, Vol.108 (1), p.58-62

2008

Volltextzugriff (PDF)

The role of the fallopian tube in ovarian cancer

Clinical advances in hematology & oncology, 2012-05, Vol.10 (5), p.296-306

2012

Volltextzugriff (PDF)

Ovarian cancer screening: UKCTOCS trial

The Lancet (British edition), 2016-06, Vol.387 (10038), p.2602-2603

2016

Volltextzugriff (PDF)

Preoperative Radiotherapy for Inoperable Stage II Endometrial Cancer: Insights into Improving Treatment and Outcomes

Journal of obstetrics and gynaecology Canada, 2013-07, Vol.35 (7), p.635-639

2013

Volltextzugriff (PDF)

Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma

Blood, 1997-07, Vol.90 (1), p.244-251

1997

Volltextzugriff (PDF)

Identifying patients unlikely to benefit from further chemotherapy: A descriptive study of outcome at each relapse in ovarian cancer

Gynecologic oncology, 2005-06, Vol.97 (3), p.862-869

2005

Volltextzugriff (PDF)

Targeted surgical prevention of epithelial ovarian cancer is cost effective and saves money in BRCA mutation carrying family members of women with epithelial ovarian cancer. A Canadian model

Gynecologic oncology, 2019-04, Vol.153 (1), p.87-91

2019

Volltextzugriff (PDF)

Canadian cost-effectiveness model of BRCA-driven surgical prevention of breast/ovarian cancers compared to treatment if cancer develops

International journal of technology assessment in health care, 2020-04, Vol.36 (2), p.104-112

2020

Volltextzugriff (PDF)

1 – 25 von 336

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(276)
Mit Volltextzugriff
(297)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(203)
Life Sciences & Biomedicine
(177)
Humans
(144)
Female
(106)
Middle Aged
(75)
Oncology
(69)
Biological And Medical Sciences
(62)
Adult
(61)
Aged
(59)
Medical Sciences
(58)
Male
(56)
Obstetrics & Gynecology
(41)
Tumors
(30)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(26)
Chemotherapy
(26)
Aged, 80 And Over
(23)
Neoplasm Staging
(23)
Physical Sciences
(23)
Animals
(21)
Ovarian Cancer
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Missed therapeutic and prevention opportunities in women with BRCA‐mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature

Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group

Low-Stage Ovarian Clear Cell Carcinoma: Population-Based Outcomes in British Columbia, Canada, With Evidence for a Survival Benefit As a Result of Irradiation

International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: Altered Utility in the Modern Era

Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma

Single or two drug combination therapy as initial treatment for low risk, gestational trophoblastic neoplasia. A Canadian analysis

Phase II Study of Erlotinib in Recurrent or Metastatic Endometrial Cancer: NCIC IND-148

Time for a level playing field: inequalities in regulatory/approval processes—the example of bevacizumab in epithelial ovarian cancer

Paclitaxel and Carboplatin, Alone or With Irradiation, in Advanced or Recurrent Endometrial Cancer: A Phase II Study

Which is the better surgical strategy for newly diagnosed epithelial ovarian cancer: primary or interval debulking?

Early-Stage Endometrioid Ovarian Carcinoma: Population-Based Outcomes in British Columbia

Triple cytotoxic therapy for advanced ovarian cancer: a failed application, not a failed strategy

Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines

Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma

Survival Benefit of Adjuvant Radiotherapy: An Analysis of Low-Stage Invasive Ovarian Mucinous Carcinomas

Reuse of carboplatin and paclitaxel in patients with relapsed endometrial cancer—the British Columbia Cancer Agency experience

Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: Potential implications for future prophylaxis recommendations

Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience

The role of the fallopian tube in ovarian cancer

Ovarian cancer screening: UKCTOCS trial

Preoperative Radiotherapy for Inoperable Stage II Endometrial Cancer: Insights into Improving Treatment and Outcomes

Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma

Identifying patients unlikely to benefit from further chemotherapy: A descriptive study of outcome at each relapse in ovarian cancer

Targeted surgical prevention of epithelial ovarian cancer is cost effective and saves money in BRCA mutation carrying family members of women with epithelial ovarian cancer. A Canadian model

Canadian cost-effectiveness model of BRCA-driven surgical prevention of breast/ovarian cancers compared to treatment if cancer develops

Suchergebnisse filtern